Genentech USA, Inc
Genentech USA, Inc received $940K in federal prime contract obligations in the 12 months ending Oct 5, 2026, up 100.3% from −$313.4M the year before, and $168.1M since FY2022. Its largest customer is the Department of Health and Human Services.
See 2 contracts ending in the next 18 months ↓Contractor details
- Unique Entity ID (UEI)
- SA85BMHCTXK5
- CAGE code
- 53VP4
- Headquarters
- South SAN Francisco, CA
- Business size
- Other Than Small Business
- Parent company
- Roche Holding AG (UEI WJHDT127L353)
As recorded on this UEI's most recent prime contract action in USAspending.gov. Confirm current registration and certifications in SAM.gov.
Obligations by fiscal year
Net prime contract obligations by federal fiscal year.
Markets where it ranks top 10
Agency and NAICS markets where this UEI is one of the ten largest primes in the latest 12 months.
Top agencies
Funding agencies ranked by obligations since FY2022.
| Funding agency | Latest 12 mo | Since FY2022 |
|---|---|---|
| Department of Health and Human Services | −$187 | $164.6M |
| Department of Defense | $940K | $3.4M |
| Department of Justice | $0 | $127K |
Top NAICS codes
Industry codes agencies recorded on this contractor's awards, since FY2022.
| NAICS | Industry | Latest 12 mo | Since FY2022 |
|---|---|---|---|
| 325412 | Pharmaceutical Preparation Manufacturing | $940K | $168.1M |
What it sells
Product and service codes (PSC) on this contractor's awards, since FY2022.
| PSC | Description | Since FY2022 |
|---|---|---|
| 6505 | Drugs and Biologicals | $106.6M |
| 3650 | Chemical and Pharmaceutical Products Manufacturing Machinery | $60.0M |
| 6515 | Medical and Surgical Instruments, Equipment, and Supplies | $916K |
| 6545 | Replenishable Field Medical Sets, Kits, and Outfits | $542K |
Contracts ending in the next 18 months
This contractor's largest awards whose current period of performance ends soon. Options and extensions often move these dates.
| Award | Agency | Obligated | Current end |
|---|---|---|---|
| SPE2D026F0182 | Department of Defense 8512097379!OTHER MEDICAL | $912K | Jun 22, 2027 |
| 75A50325F80036 | Department of Health and Human Services PROCURENT OF XOFLUZA (BALOXAVIR MARBOXIL) 40MG AND 80MG TABLETS | $37.5M | Sep 29, 2027 |
Recent awards
This contractor's newest prime contract awards, most recent first.
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| SPE2D326F117U | Department of Defense 4571907151!TAMIFLU 75 MG CAPSULE 10S | $3K | May 13, 2026 |
| SPE2D026F0182 | Department of Defense 8512097379!OTHER MEDICAL | $912K | May 11, 2026 |
| SPE2D326F025W | Department of Defense 4571520559!TNKASE 50 MG KITS | $6K | Apr 15, 2026 |
| SPE2D326F4685 | Department of Defense 4570666861!TNKASE 50 MG KITS | $17K | Jan 27, 2026 |
| SPE2D326F2218 | Department of Defense 4570295090!TAMIFLU 75 MG CAPSULE 10S | $1K | Dec 8, 2025 |
| 75A50325F80036 | Department of Health and Human Services PROCURENT OF XOFLUZA (BALOXAVIR MARBOXIL) 40MG AND 80MG TABLETS | $37.5M | Sep 26, 2025 |
| SPE2D325F462J | Department of Defense 4569634525!TNKASE 50 MG KITS | $21K | Sep 26, 2025 |
| SPE2D325F386E | Department of Defense 4569386624!TAMIFLU 75 MG CAPSULE 10S | $1K | Sep 4, 2025 |
Other Roche Holding AG entities
UEIs that report the same ultimate parent in SAM.gov. Ownership records can lag acquisitions.
Prime contracts (award types A–D) from USAspending.gov through Oct 5, 2026. Subcontracts are not included. Net obligations include deobligations and corrections.
Ready to connect your pursuit work?
GovEagle gives BD directors, capture managers, and proposal teams one AI workspace from pipeline through proposal, with CMMC/FedRAMP Certified compliance built in.